BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2015
View Archived Issues
Prevention of HIV transcription from latency by Tat inhibitor
Read More
BioRestorative Therapies to evaluate encapsulation technology for use in metabolic program
Read More
Dauntless Pharmaceuticals closes series A financing, licenses technology from Aegis
Read More
KalVista Pharmaceuticals raises funds to advance plasma kallikrein inhibitor pipeline
Read More
Merck & Co.'s Keytruda approved in Europe for advanced melanoma
Read More
Novartis presents milestones of second quarter 2015
Read More
Discovery and optimization of a pan-RET/VEGFR-2 dual inhibitor for single-agent polypharmacology
Read More
New organotypic brain slice culture model helps elucidate Alzheimer's disease pathology
Read More
Horizon Pharma increases share offer for Depomed
Read More
CNGA2 KO mice show AD-like pathological features
Read More
Beaufour Ipsen Tianjin Pharmaceutical describes AR degraders
Read More
Intra-Cellular Therapies plans phase III program for ITI-007 in bipolar depression
Read More
Polyphor reports selective elastase inhibitors
Read More
Catalyst initiates rolling NDA for Firdapse in LEMS
Read More
West China Hospital, Sichuan University reports short-acting anesthesic
Read More
Novartis files sBLA for ofatumumab as maintenance therapy for relapsed CLL
Read More
Alectos Therapeutics designs GCase inhibitors
Read More
Erum Biotechnologies patents PTP-1B inhibitors
Read More
Vidasym's phosphate binder VS-505 enters phase I/II trial
Read More
Phase I study investigates T4 immunotherapy for head and neck cancer
Read More
Xoma reports data from phase III EYEGUARD-B study
Read More
Roche Diagnostics launches HTLV blood test
Read More
AMAG Pharmaceuticals obtains option to acquire digoxin immune fab for pre-eclampsia
Read More
NIH funds collaborative project to develop measures of social impairment in autism
Read More
